United Therapeutics Corp. (UTHR)
570.40
-0.95
(-0.17%)
USD |
NASDAQ |
May 01, 16:00
570.43
+0.03
(+0.01%)
After-Hours: 20:00
United Therapeutics EPS Diluted (Quarterly) : 7.702 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| MannKind Corp. | -0.0519 |
| Catalyst Pharmaceuticals, Inc. | 0.4136 |
| Insmed, Inc. | -1.538 |
| Eli Lilly & Co. | 8.255 |
| Johnson & Johnson | 2.141 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 364.30M |
| Revenue (Quarterly) | 790.20M |
| Total Expenses (Quarterly) | 425.90M |
| Enterprise Value | 22.08B |
| Gross Profit Margin (Quarterly) | 86.91% |
| Profit Margin (Quarterly) | 46.10% |
| Earnings Yield | 4.89% |
| Operating Earnings Yield | 5.55% |
| Normalized Earnings Yield | 4.825 |